Your session is about to expire
← Back to Search
D2C7-IT + 2141-V11 for Brain Cancer
Study Summary
This trial is testing a new drug combination for brain cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am able to care for myself but may not be able to do active work.I have worsening muscle weakness and muscle loss in my arms and legs.I haven't had immunotherapy in the last 4 weeks or have recovered from its side effects.I have severe lung disease or my diabetes is not under control.My recent biopsy confirmed the recurrence of my tumor.I have taken more than 4 mg of dexamethasone daily in the last 2 weeks.My tumor has or might have a specific genetic feature, and I've had chemotherapy before.My blood clotting tests are normal, and if I'm on blood thinners, they're managed as per guidelines.My tumor's MGMT promoter is unmethylated, so I haven't had to undergo chemotherapy before this trial.I haven't had chemotherapy or bevacizumab in the last 4 weeks, or if I did, I've recovered from the side effects.I am not currently being treated for cancer, except for early-stage cervical, basal cell, or squamous cell skin cancer.My cancer has spread to my brainstem, cerebellum, or spinal cord and is actively growing.My kidney function tests are within normal limits.I do not have severe heart disease.I have an immunosuppressive disease or HIV.I do not have an active infection needing IV treatment or a fever over 99.5°F.My platelet count is at least 100,000/µl without help, and over 125,000/µl for biopsy procedures.I haven't had radiation therapy in the last 12 weeks, or if I have, my cancer has still grown.You have a serious and ongoing health issue that could interfere with your ability to participate in the study.You are allergic to albumin.I cannot become pregnant or get someone pregnant.I have an autoimmune disease but haven't needed systemic treatment for it in the last 3 months.You are able to have an MRI scan of your brain with a special dye if needed.My brain tumor is a high-grade glioma confirmed by tissue analysis.I am 18 years old or older.I am not pregnant or breastfeeding.I have not used tumor treating fields like Optune in the last week.I haven't finished all standard treatments, including surgery and radiation.
- Group 1: D2C7-IT + 2141-V11
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the current enrollment quota for this research endeavor?
"Affirmative. The clinicaltrials.gov website reveals that this study is actively searching for volunteers, having been initially posted on July 9th 2021 and recently updated in late July 2022. 30 participants will be enrolled at 1 location."
Are participants still welcome to join this investigation?
"Affirmative. According to the clinicaltrials.gov database, this trial is currently recruiting patients; it was initially put up on July 9th 2021 and updated lastly on July 27th 2022. The study necessitates 30 participants from a single medical centre."
Has the FDA sanctioned D2C7-IT for use in medical treatments?
"Our experts at Power rate D2C7-IT's safety as a 1 because it is in the earliest trial phase and there is only scant clinical evidence confirming its efficacy."
Share this study with friends
Copy Link
Messenger